Marshall Wace’s Evoke Pharma EVOK Stock Holding History

Marshall Wace’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-642	Closed	-$139K	–	1482
2019 Q1	$139K	Buy	+642	New	+$219K	﹤0.01%	1390

Other funds holding EVOK

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace's EVOK Position: Q2 2019 in Review

Marshall Wace sold out of Evoke Pharma (EVOK) in Q2 2019, closing a stake of 642 shares — an estimated $139K sold.

Marshall Wace first reported a position in EVOK in Q1 2019 and held it in 1 quarter. The position peaked at $139K in Q1 2019. 19 funds tracked by Wall St. Rank hold EVOK as of Q2 2019.

Marshall Wace reported no remaining Evoke Pharma position as of Q2 2019 after selling out during the quarter.
Marshall Wace sold 642 Evoke Pharma shares in Q2 2019, an estimated $139K.
Marshall Wace first reported a position in Evoke Pharma in Q1 2019 and held it in 1 quarter.
Marshall Wace's Evoke Pharma position peaked at $139K in Q1 2019.
19 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2019.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.